Brandinium

Trademark search for:

ARMOLIPID

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2014-03-07 — Application filed
  • 2014-04-10 — Sn assigned for sect 66a subseq desig from ib
  • 2014-04-14 — Application filed
  • 2014-04-15 — Application filed
  • 2014-04-19 — Application filed
  • 2014-06-12 — Assigned to examiner
  • 2014-06-16 — Final disposition recorded
  • 2014-06-17 — Office action issued
  • 2014-06-17 — Office action issued
  • 2014-06-17 — Office action issued
  • 2014-07-12 — Office action issued
  • 2014-12-09 — Office action issued
  • 2014-12-09 — Correspondence received in law office
  • 2014-12-09 — Teas/email correspondence entered
  • 2014-12-29 — Office action issued
  • 2014-12-30 — Office action issued
  • 2015-01-02 — International registration renewed
  • 2015-03-04 — Teas request for reconsideration received
  • 2015-03-04 — Correspondence received in law office
  • 2015-03-04 — Teas/email correspondence entered
  • 2015-03-05 — Approved for pub - principal register
  • 2015-03-24 — Assigned to lie
  • 2015-03-25 — Law office publication review completed
  • 2015-04-07 — Withdrawn from pub - og review query
  • 2015-05-01 — Previous allowance count withdrawn
  • 2015-05-01 — Final disposition recorded
  • 2015-05-04 — Final disposition recorded
  • 2015-06-19 — Total invalidation processed by the ib
  • 2015-07-11 — Office action issued
  • 2015-07-31 — Examiners amendment -written
  • 2015-07-31 — Examiner's amendment entered
  • 2015-08-03 — Examiners amendment mailed
  • 2015-08-03 — Approved for pub - principal register
  • 2015-08-03 — Law office publication review completed
  • 2015-08-19 — Notice of start of opposition period created, to be sent to ib
  • 2015-08-19 — Notice of publication
  • 2015-08-19 — Notification of possible opposition sent to ib
  • 2015-09-08 — Published for opposition
  • 2015-09-16 — Notification of possible opposition created, to be sent to ib
  • 2015-09-16 — Notification of possible opposition sent to ib
  • 2015-10-02 — Notification of possible opposition - processed by ib
  • 2015-10-02 — Notification processed by ib
  • 2015-11-24 — Registered-principal register
  • 2016-02-24 — Final disposition recorded
  • 2016-02-26 — Final disposition recorded
  • 2016-02-26 — Final disposition recorded
  • 2016-05-05 — Final disposition recorded
  • 2019-08-30 — Teas change of correspondence received
  • 2020-11-24 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2022-06-10 — Cancelled section 71
  • 2023-02-10 — Total invalidation of reg ext protection created
  • 2023-06-06 — New representative at ib received
  • 2024-12-02 — New representative at ib received
  • 2024-12-15 — Final status recorded
  • 2025-07-05 — Death of international registration
  • 2025-07-05 — Notification of effect of cancellation of intl reg e-mailed

Owner Information

ROTTAPHARM SPA
IT
ROTTAPHARM SPA
IT
ROTTAPHARM SPA
IT

Correspondent

Edward E. Vassallo and Lisa Mottes Fitzpatrick Cella Harper & Scinto
1290 Avenue Of The Americas Fl 19
New York, NY 10104-3800
UNITED STATES

Filing Details

Filing Date:
2014-03-07
Status Date:
2024-12-15
Category:
Pharmaceuticals
Filing Year:
2006

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.